ENO2 and Merkel cell skin cancer: We found that despite the reported utility of NSE and ChrA blood levels as biomarkers for low grade NETs, clinical use of NSE and ChrA levels in MCC patients failed to correlate with outcomes, disease progression, or tumor burden.